Infiniti Feed

Senators seek HHS answers on drug trial and approval markets

Senators Angela Alsobrooks and Ron Wyden wrote to Health and Human Services Secretary Robert F. Kennedy Jr. asking what measures HHS has taken to mitigate risks from prediction market event contracts on clinical drug trials and FDA regulatory approvals. Global Gaming Insider reported the letter amid growing political scrutiny of the contract category.

Senators Angela Alsobrooks and Ron Wyden have asked Health and Human Services Secretary Robert F. Kennedy Jr. how his department is addressing risks associated with prediction markets tied to drug development, according to Global Gaming Insider.

Their letter concerns event contracts involving clinical drug trials and FDA regulatory approvals. The senators asked what measures HHS has taken to mitigate risks from those contracts.

Scrutiny of health-related contracts

Global Gaming Insider reported the letter amid growing political scrutiny of this category of prediction-market contracts. The inquiry puts HHS’s response to those risks at the center of the senators’ questions.

The available summary does not describe specific safeguards, identify particular contracts or platforms, or include a response from HHS. It therefore provides no basis for concluding that the inquiry has led to a policy change.

What it means for prediction markets

  • A defined area of scrutiny: The letter targets contracts on clinical drug trials and FDA regulatory approvals, rather than prediction markets generally.
  • Agency action remains unclear: The senators are asking what HHS has done; the available reporting does not establish what measures, if any, the department has taken.
  • An inquiry, not a restriction: The reported development is a request for information. No new rule or enforcement action is described in the supplied summary.
Infiniti MarketsInfiniti Signals

Sources & attribution

Published
  1. Source
    Global Gaming Insider
    Publisher
    The publisher did not list a web address.
    Source URL
    The feed did not publish this story's article address.

Full attribution under the Digital Millennium Copyright Act (DMCA), 17 U.S.C. § 512: this article is an original report by Infiniti Intelligence that summarizes the reporting of the publishers named above, links to their original work, and reproduces no protected expression beyond brief factual reference and in-line attribution (“according to Global Gaming Insider”). All rights in the underlying reporting remain with the publishers listed; nothing here implies endorsement by or affiliation with them. Rights holders may request correction, update or removal through the contact address published at infiniti.w3ai.io.